Stocks/AKTX

AKTX three-lens brief

Evidence-based stock research on AKTX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$3.02$10.88$49.60

Performance

1W
+0.4%
1M
+40.8%
3M
6M
YTD
1Y
3Y
5Y
AKTX · Nightly brief
Inspect

Moved +2.93% yesterday. · Currently unprofitable on a trailing basis — no P/E multiple available.

  • Moved +2.93% yesterday.
  • Outperforming SPY by 28.0pp over 30 days.
  • Currently unprofitable on a trailing basis — no P/E multiple available.
  • Negative free cash flow last quarterly (-$9.38M).

AKTX closed at $10.88 (+2.93%) as of 2026-09-11. Market cap: $21.18M. Price is above the 50-day MA and above the 200-day MA. Positives: moved +2.93% yesterday.; outperforming SPY by 28.0pp over 30 days.. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; negative free cash flow last quarterly (-$9.38M).. Last quarter: net income -$4.81M, free cash flow -$9.38M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on AKTX, not one.

A single reasoning model has blind spots it doesn’t know about. We examine AKTXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/AKTX"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath AKTX brief"></iframe>